Visual system involvement in patients with Friedreich's ataxia

Brain

Volumn 132, Issue 1, 2009, Pages 116-123

  Fortuna, Filippo ^a   Barboni, Piero ^a,b   Liguori, Rocco ^a   Valentino, Maria Lucia ^a   Savini, Giacomo ^c   Gellera, Cinzia ^d   Mariotti, Caterina ^d   Rizzo, Giovanni ^a   Tonon, Caterina ^a   Manners, David ^a   Lodi, Raffaele ^a   Sadun, Alfredo A ^e   Carelli, Valerio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Studio Oculistico d'Azeglio   (Italy)

^c IRCCS FONDAZIONE BIETTI   (Italy)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Frataxin; Friedreich's ataxia; Mitochondria; OCT; Optic neuropathy

Indexed keywords

WATER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE DURATION; DISEASE SEVERITY; EVOKED VISUAL RESPONSE; FEMALE; FRIEDREICH ATAXIA; HETEROZYGOTE; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; NERVE FIBER; NUCLEOTIDE SEQUENCE; ONSET AGE; OPTIC DISK; OPTIC NERVE; OPTIC NERVE DISEASE; OPTICAL COHERENCE TOMOGRAPHY; PALLOR; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIATION; RETINA NERVE CELL; SCORING SYSTEM; SYMPTOMATOLOGY; VISION; VISION TEST; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT; VISUAL SYSTEM;

ADOLESCENT; ADULT; AGE OF ONSET; BRAIN MAPPING; EVOKED POTENTIALS, VISUAL; FEMALE; FRIEDREICH ATAXIA; HUMANS; IRON-BINDING PROTEINS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; REACTION TIME; RETINAL GANGLION CELLS; SENSORY THRESHOLDS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELDS; VISUAL PATHWAYS; YOUNG ADULT;

EID: 58849095750     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn269     Document Type: Article

References (32)

1. Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homologue of frataxin. Science 1997; 276: 1709-12.
2. Barboni P, Savini G, Valentino ML, Montagna P, Cortelli P, De Negri AM, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology 2005; 112: 120-26.
3. Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, et al. Friedreich ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271: 1423-7.
4. Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 1997; 6: 1771-80.
5. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 2004; 23: 53-89.
6. Carelli V, Barboni P, Sadun AA. Mitochondrial ophthalmology. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. Oxon, UK: Informa Healthcare; 2006. p. 105-42.
7. Carelli V, La Morgia C, Iommarini L, Carroccia R, Mattiazzi M, Sangiorgi S, et al. Mitochondrial optic neuropathies: how two genomes may kill the same cell type? Biosci Rep 2007; 27: 173-84.
8. Carroll WM, Kriss A, Baraitser M, Barrett G, Halliday AM. The incidence and nature of visual pathway involvement in Friedreich's ataxia. A clinical and visual evoked potential study of 22 patients. Brain 1980; 103: 413-34.
9. Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998; 93: 973-83.
10. Cossée M, Dürr A, Schmitt M, Dahl N, Trouillas P, Allinson P, et al. Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol 1999; 45: 200-6.
11. Frisen L, Malmgren K. Characterization of vigabatrin-associated optic atrophy. Acta Ophthalmol Scand 2003; 81: 466-73.
12. Gellera C, Castellotti B, Mariotti C, Mineri R, Seveso V, Didonato S, et al. Frataxin gene point mutations in Italian Friedreich ataxia patients. Neurogenetics 2007; 8: 289-99.
13. Givre SJ, Wall M, Kardon RH. Visual loss and recovery in a patient with Fridreich Ataxia. J Neuro-ophthalmol 2000; 20: 229-33.
14. Harding AE. Clinical features and classification of inherited ataxias. Adv Neurol 1993; 61: 1-14.
15. Jin H, May M, Tranebjaerg L, Kendall E, Fontán G, Jackson J, et al. A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nat Genet 1996; 14: 177-80.
16. Koutnikova H, Campuzano V, Foury F, Dollé P, Cazzalini O, Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet 1997; 16: 345-51.
17. Ikeda H. Clinical electroretinography. In: HallidayAM, editor. Evoked potentials in clinical testing. London: Churchill Livingstone; 1982. p. 121-47.
18. Lodi R, Cooper JM, Bradley JL, Manners D, Styles P, Taylor DJ, et al. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci USA 1999; 96: 11492-95.
19. Newman NJ. Optic neuropathy as a manifestation of hereditary degenerative or developmental diseases. Hereditary ataxias. In: Miller NR, Newman NJ, Biousse V, Kerrison JB, editors. Walsh and Hoyt's clinical neuroopthalmology. Baltimore: Lippincott Williams & Wilkins; 2005. p. 482-84.
20. Nicoletti G, Lodi R, Condino F, Tonon C, Fera F, Malucelli E, et al. Apparent diffusion coefficient measurements of the Middle Cerebellar Peduncle differentiate the Parkinson variant of MSA from PD and PSP. Brain 2006; 129: 2679-87.
21. Porter N, Downes SM, Fratter C, Anslow P, Nemeth AH. Catastrophic visual loss in a patient with Friedreich ataxia. Arch Ophthalmol 2007; 125: 273-74.
22. Rötig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 1997; 17: 215-17.
23. Savini G, Barboni P, Valentino ML, Montagna P, Cortelli P, De Negri AM, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. Ophthalmology 2005; 112: 127-31.
24. Seznec H, Simon D, Bouton C, Reutenauer L, Hertzog A, Golik P, et al. Friedreich ataxia, the oxidative stress paradox. Hum Mol Genet 2005; 14: 463-74.
25. Shan Y, Napoli E, Cortopassi G. Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones. Hum Mol Genet 2007; 16: 929-41.
26. Tan G, Napoli E, Taroni F, Cortopassi G. Decreased expression of genes involved in sulfur amino acid metabolism in frataxin deficient cells. Hum Mol Genet 2003; 12: 1699-711.
27. Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997; 145: 205-11.
28. Wilson RB, Roof DM. Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nat Genet 1997; 16: 352-57.
29. Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F, et al. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet 1999; 8: 425-30.
30. Yamamoto T, Yamada K, Nishimura T, Kinoshita S. Tractography to depict three layers of visual field trajectories to the calcarine gyri. Am J Ophthalmol 2005; 140: 781-85.
31. Zanna C, Ghelli A, Porcelli AM, Karbowski M, Youle RJ, Schimpf S, et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008; 131: 352-67.
32. Züchner S, De Jonghe P, Jordanova A, Claeys KG, Guergueltcheva V, Cherninkova S, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol 2006; 59: 276-81.